Danielle Satterthwaite

Danielle Satterthwaite is an accomplished leader in the pharmaceutical industry with extensive experience in rare diseases and CNS specialties. Currently serving as the Rare Disease Business Director at Amryt Pharma plc since July 2020, Danielle leads a team of 10 across the eastern US, overseeing key assets such as Juxtapid, Myalept, and Mycapssa. Previous roles include Regional Business Director East at Adamas Pharmaceuticals, where Danielle earned recognition as Regional Business Director of the Year and a 2019 Pinnacle Club Winner. Danielle also held positions at Lundbeck and Ovation Pharmaceuticals, achieving distinction with awards such as the All Star Award and the Starfire Award. Danielle started the career at The Janssen Pharmaceutical Companies, focusing on various therapeutic areas. Danielle holds a Bachelor of Arts degree in Communication and Media Studies from Temple University.